Self-administered succus entericus reinfusion before ileostomy closure improves short-term outcomes.

Area of Science:

• Gastroenterology
• Surgical Oncology
• Colorectal Surgery

Background:

• Postoperative recovery after ileostomy closure can be prolonged.
• Optimizing prehabilitation strategies is crucial for improving patient outcomes.
• Succus entericus reinfusion (SER) is a potential intervention to enhance recovery.

Purpose of the Study:

• To evaluate the impact of succus entericus reinfusion (SER) prior to ileostomy closure.
• To assess SER's effect on postoperative length of stay.
• To determine SER's influence on the low anterior resection score (LARS).

Main Methods:

• Retrospective analysis of prospectively collected data from May 2016 to November 2019.
• Comparison of 30 patients receiving SER with 42 patients in a non-SER control group.
• Data collection included time to gastrointestinal function recovery, length of stay, and LARS.

Main Results:

• No significant difference in postoperative ileus incidence between groups.
• SER group showed significantly shorter time to first flatus/stool (27.9 vs. 32.3 hours, p=0.004).
• SER group had a shorter postoperative length of stay (4.90 vs. 5.52 days, p=0.009) and lower LARS at 1 week (p=0.034).

Conclusions:

• Self-administered SER is a feasible outpatient prehabilitation strategy.
• SER significantly improves gastrointestinal recovery and shortens hospital stay.
• SER enhances short-term quality of life without increasing complications.